180 related articles for article (PubMed ID: 15231658)
1. Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout cells to antitumor triazoloacridone C-1305 is associated with permanent G2 cell cycle arrest.
Wesierska-Gadek J; Schloffer D; Gueorguieva M; Uhl M; Skladanowski A
Cancer Res; 2004 Jul; 64(13):4487-97. PubMed ID: 15231658
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
Wesierska-Gadek J; Schmid G
Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635
[TBL] [Abstract][Full Text] [Related]
3. Action of a novel anticancer agent, CHS 828, on mouse fibroblasts: increased sensitivity of cells lacking poly (ADP-Ribose) polymerase-1.
Lövborg H; Wojciechowski J; Larsson R; Wesierska-Gadek J
Cancer Res; 2002 Aug; 62(15):4206-11. PubMed ID: 12154020
[TBL] [Abstract][Full Text] [Related]
4. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
Smith LM; Willmore E; Austin CA; Curtin NJ
Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308
[TBL] [Abstract][Full Text] [Related]
5. Triazoloacridone C-1305 abrogates the restriction checkpoint in cells lacking functional p53 and promotes their accumulation in the G2/M phase of the cell cycle.
Maurer M; Komina O; Składanowski A; Wesierska-Gadek J
J Exp Ther Oncol; 2011; 9(1):5-15. PubMed ID: 21275261
[TBL] [Abstract][Full Text] [Related]
6. Increased cytotoxicity of an unusual DNA topoisomerase II inhibitor compound C-1305 toward HeLa cells with downregulated PARP-1 activity results from re-activation of the p53 pathway and modulation of mitotic checkpoints.
Sabisz M; Wesierska-Gadek J; Skladanowski A
Biochem Pharmacol; 2010 May; 79(10):1387-97. PubMed ID: 20067769
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
Bowman KJ; Newell DR; Calvert AH; Curtin NJ
Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
[TBL] [Abstract][Full Text] [Related]
8. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
[TBL] [Abstract][Full Text] [Related]
9. Major contribution of the multidrug transporter P-glycoprotein to reduced susceptibility of poly(ADP-ribose) polymerase-1 knock-out cells to doxorubicin action.
Wesierska-Gadek J
J Cell Biochem; 2005 Aug; 95(5):1012-28. PubMed ID: 15861398
[TBL] [Abstract][Full Text] [Related]
10. Integrin-mediated suppression of endotoxin-induced DNA damage in lung endothelial cells is sensitive to poly(ADP-ribose) polymerase-1 gene deletion.
Huang H; McIntosh JL; Fang L; Szabo C; Hoyt DG
Int J Mol Med; 2003 Oct; 12(4):533-40. PubMed ID: 12964031
[TBL] [Abstract][Full Text] [Related]
11. Activation of p53 protein in normal and in tumor cells by a novel anticancer agent CHS 828.
Wojciechowski J; Lövborg H; Wesierska-Gadek J
Drugs Exp Clin Res; 2003; 29(2):53-67. PubMed ID: 12951835
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of poly(ADP-ribose) polymerase activity accelerates T-cell lymphomagenesis in p53 deficient mice.
Beneke R; Möröy T
Oncogene; 2001 Dec; 20(56):8136-41. PubMed ID: 11781827
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase in base excision repair: always engaged, but not essential for DNA damage processing.
Allinson SL; Dianova II; Dianov GL
Acta Biochim Pol; 2003; 50(1):169-79. PubMed ID: 12673357
[TBL] [Abstract][Full Text] [Related]
14. Reduced stability of regularly spliced but not alternatively spliced p53 protein in PARP-deficient mouse fibroblasts.
Wesierska-Gadek J; Wang ZQ; Schmid G
Cancer Res; 1999 Jan; 59(1):28-34. PubMed ID: 9892179
[TBL] [Abstract][Full Text] [Related]
15. Increased resistance to anticancer therapy of mouse cells lacking the poly(ADP-ribose) polymerase attributable to up-regulation of the multidrug resistance gene product P-glycoprotein.
Wurzer G; Herceg Z; Wesierska-Gadek J
Cancer Res; 2000 Aug; 60(15):4238-44. PubMed ID: 10945636
[TBL] [Abstract][Full Text] [Related]
16. G2/M cell-cycle arrest and apoptosis by n-3 fatty acids in a pancreatic cancer model.
Dekoj T; Lee S; Desai S; Trevino J; Babcock TA; Helton WS; Espat NJ
J Surg Res; 2007 May; 139(1):106-12. PubMed ID: 17291531
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle progression and apoptosis after irradiation in an acidic environment.
Park HJ; Lyons JC; Ohtsubo T; Song CW
Cell Death Differ; 2000 Aug; 7(8):729-38. PubMed ID: 10918447
[TBL] [Abstract][Full Text] [Related]
18. Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase.
Agarwal ML; Agarwal A; Taylor WR; Wang ZQ; Wagner EF; Stark GR
Oncogene; 1997 Aug; 15(9):1035-41. PubMed ID: 9285557
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed poly(ADP-ribose) polymerase delays the release of rat cells from p53-mediated G(1) checkpoint.
Wesierska-Gadek J; Schmid G
J Cell Biochem; 2000 Sep; 80(1):85-103. PubMed ID: 11029756
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of the p53 response to DNA strand breaks in cells depleted of PARP by antisense RNA expression.
Simbulan-Rosenthal CM; Rosenthal DS; Ding R; Bhatia K; Smulson ME
Biochem Biophys Res Commun; 1998 Dec; 253(3):864-8. PubMed ID: 9918821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
